MRNA spotlight — 2026-10-28
Moderna (MRNA) shares rose 4.59% on Tuesday, closing at $207.97 on 17.64 million shares. This move comes after a difficult five-session stretch where the stock returned -14.09%.
Key figures
Data as of Oct 28, 2026- MRNA last close
- $207.97
- MRNA change vs prior close
- 4.59%
- MRNA market cap
- $83.04B
Moderna (MRNA) shares rose 4.59%¹ on Tuesday, closing at $207.97² on 17.64 million shares³. This move comes after a difficult five-session stretch where the stock returned -14.09%⁴.
Despite the recent dip, MRNA remains in a strong long-term uptrend, with a 12-month return of 677.75%⁵ and a 3-month return of 281.67%⁶. The stock is currently positioned at 80.0% of its 52-week range⁷, sitting between a low of $22.28 and a high of $254.48⁸˒⁹. It is also trading 148.01% above its 200-day average¹⁰.
From a fundamental perspective, the company's $83.04B market cap¹¹ exists alongside a lack of profitability in its latest report, which showed an EPS of -1.97¹² on revenue of $145.00M¹³. Recent news sentiment remains mixed, with five neutral, two negative, and one positive headline.
Moderna, Inc. Common Stock (MRNA): price and news
Full chart and figuresEducational tool. Not investment advice. This article was produced with automated assistance. Every figure in it was checked against the underlying data before it was published; the interpretation was not.